In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin

Acta Clinica Belgica

Volumn 51, Issue 4, 1996, Pages 237-243

  Delmee M ^a   Carpentier, M ^b   Glupczynski, Y ^c   Gordts, B ^d   Magerman, K ^e   Simon, A ^f   Surmont, I ^g   Van De Vyvere, M ^h   Van Landuyt, H ^d   Van Nimmen, L ⁱ   Van Noyen, R ^j  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Centre Hospitalier Regional de La Citadelle   (Belgium)

^c Laboratoire de Microbiologie   (Belgium)

^d General Hospital St Jan   (Belgium)

^e VIRGA JESSE HOSPITAL   (Belgium)

^f Laboratoire de Microbiologie   (Belgium)

^g Heilig Hart Ziekenhuis   (Belgium)

^h Stuivenberg General Hospital   (Belgium)

ⁱ City Hospital De Bijloke   (Belgium)

^j IMELDA HOSPITAL   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFACLOR; CEFOTAXIME; CEFUROXIME; CLARITHROMYCIN; CLAVULANIC ACID;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFACLOR; CEFOTAXIME; CEFUROXIME; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; CLAVULANIC ACIDS; CROSS INFECTION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 10144222898     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mathies AW Jr. Penicillins in the treatment of bacterial meningitis. J Roy Coll Phycns Lond. 1972; 6: 139-46.
2. Thomas WJ, McReynolds JW, Mock CR, Bailey DW. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet. 1974; i: 313.
3. Turk DC. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet. 1974; i: 453.
4. Clymo AB, Harper IA. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet. 1974; i: 453-4.
5. Price E, Boswell PA. Ampicillin-resistant Haemophilus influenzae. Lancet. 1974; i: 936-7.
6. Gunn BA, Woodall JB, Jones JF, Thornsberry C. Ampicillin-resistant Haemophilus influenzae. Lancet. 1974; ii: 845.
7. Khan W, Ross S, Rodriguez W, Controni G, Saz AK. Haemophilus influenzae type b resistant to ampicillin. JAMA. 1974; 229: 298-301.
8. Eickhoff TC, Ehret JM, Dixie Baines R. Characterization of an ampicillin-resistant Haemophilus influenzae type b. Antimicrob Agents Chemother. 1976; 9: 889-92.
9. Medeiros AA, O'Brien TF. Ampicillin-resistant Haemophilus influenzae type b possessing a TEM-type, β-lactamase but little permeability barrier to ampicillin. Lancet. 1975; i: 716-9.
10. Markowitz SM. Isolation of an ampicillin-resistant, non β-lactamase-producing strain of Haemophilus influenzae. Antimicrob Agents Chemother. 1980; 17: 80-3.
11. Fuchs PC, Barry AL. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxycillin, and amoxycillin-clavulanic acid. J Clin Microbiol. 1994; 32: 2846-50.
12. Barry AL, Fuchs PC, Pfaller MA. Susceptibilities of β-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxycillin-clavulanic acid. Antimicrob Agents Chemother. 1993; 37: 14-8.
13. Baquero F, Loza E. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr Infect Dis J. 1994; 13: S9-14.
14. Goldstein FW, Acar JF. Epidemiology of antibiotic resistance in Haemophilus influenzae. Microb Drug Resistance. 1995; 1: 131-5.
15. Kilian M. Haemophilus. In: Balows A, Ed. Manual of Clinical Microbiology. Fifth Edition. Washington, D.C.: ASM. 1991: 463-70.
16. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. NCCLS Document M7-A3, Vol. 13 No. 25, Villanova PA, 1993.
17. Kayser FH, Morenzoni G, Santanam P. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis. 1990; 9: 810-7.
18. Jordens JZ, Slack MPE. Haemophilus influenzae: then and now. Eur J Clin Microbiol Infect Dis. 1995; 14: 935-48.
19. Ducoffre G. Surveillance des maladies infectieuses par un réseau de laboratoires de microbiologie, 1994 + rétrospective 1983-1993. Rapport de l'Institut d'Hygiène et d'Epidémiologie. Décembre 1995: 28-30.
20. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother. 1994; 38: 2419-25.
21. Barry AL, Fuchs PC. Susceptibility of bacterial respiratory tract pathogens to amoxycillin and amoxycillin-clavulanic acid. Eur J Clin Microbiol Infect Dis. 1994; 13: 442-4.
22. Scriver SR, Walmsley SL, Kau CL, et al. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterisation of their β-lactamases. Antimicrob Agents Chemotner. 1994; 38: 1678-80.
23. Dabernat H, Seguy M, Delmas C. Situation 1993 de la resistance aux antibiotiques chez Haemophilus influenzae en France (bilan du Centre National de Référence pour H. influenzae). Méd Mal Infect. 1994; 24: 1244-47.
24. Delmée M, Glupczynski Y, Gordts B, Van Landuyt H, Van Noyen R. Amoxycillin/clavulanate and Haemophilus influenzae. Acta Clin Belg. 1994; 49: 311-2.
25. Verbist L, Dhoore F. In vitro susceptibility of recently isolated respiratory tract pathogens to mino-cycline and comparable antibiotics. A multicentre study. Acta Clin Belg. 1994; 49: 268-73.
26. Hussey G, Hitchcock J, Hanslo D, et al. Serotypes and antimicrobial susceptibility of Haemophilus influenzae. J Antimicrob Chemother. 1994; 34: 1031-36.
27. Fass RJ. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. Antimicrob Agents Chemother. 1993; 37: 2080-86.
28. Barry AL, Fuchs PC, Brown SD. Relative potenties of azithromycin, clarithromycin, and five other orally administered antibiotics. J Antimicrob Chemother. 1995; 35: 552-5.
29. Peters DH, Clissold SP. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs. 1992; 44: 117-64.
30. Peters DH, Friedel AH, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1992; 44: 750-99.